Skip to main content

Advertisement

Log in

Accuracy of Oral 67Gallium Citrate Scintigraphy in assessment of inflammatory activity of Crohn’s disease

  • Original Article
  • Published:
Annals of Nuclear Medicine Aims and scope Submit manuscript

A Letter to the Editor to this article was published on 30 April 2020

Abstract

Aim

The main goal in Crohn´s disease (CD) is a sustained suppression of inflammatory activity associated with mucosa healing in endoscopic evaluation. During clinical routine, there are small numbers of good markers to monitor inflammatory activity under treatment. We postulated that Oral 67Gallium Citrate Scintigraphy is able to mark inflammatory disease in mucosa and deep inflammation in CD, when used in oral form.

Objective

Measure the accuracy of Oral 67Gallium Citrate Scintigraphy in intestinal inflammatory activity of Crohn´s disease.

Patients and methods

In a prospective consecutive cross-sectional study from January 2018 to June 2019, the ileocolonic region of 32 patients with CD were studied by dividing into four regions of interest (ROI) from the ileum to the rectum. A total of 128 intestinal segments were analyzed in cluster data. Accuracy values of Oral 67Gallium Scintigraphy and colonoscopy tests were evaluated with the histological reference test. Values of the respective receiver operating characteristic (ROC) curves were obtained  and compared. The reliability between the tests was evaluated by Kappa statistical with the segment-level analyses using variance adjustments. All statistical analyses were performed with a test significance level of 0.05.

Results

The study population included 32 patients with CD (10 men, 22 women; average age 39 years). Disease time was five years on average. Anti-TNFs treatment was found in 71%. The most found phenotype of the Montreal classification was L3. Differences in ROC curves for colonoscopy (0.94) and Oral 67Ga Scintigraphy (0.96) did not show significant value (p = 0.32). The sensitivity of scintigraphy to detect intestinal inflammatory activity in CD was 64%, specificity of 96% and accuracy of 84%. A high agreement was found between oral scintigraphy and histological measurements with kappa = 0.64.

Conclusions

Oral 67Ga Scintigraphy had similar accuracy and agreement compared to colonoscopy in the identification of inflammatory activity in Crohn´s Disease. This new approach may be useful and less invasive for long term follow-ups.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6

Similar content being viewed by others

References

  1. Mazzuoli S, Guglielmi FW, Antonelli E, Salemme M, Bassotti G, Villanacci V. Definition and evaluation of mucosal healing in clinical practice. Dig Liver Dis. 2013;45(12):969–77.

    Article  PubMed  Google Scholar 

  2. Maconi G, Armuzzi A. Beyond remission and mucosal healing in Crohn's disease. Exploring the deep with cross sectional imaging. Dig Liver Dis. 2017;49(5):457–8.

    Article  PubMed  Google Scholar 

  3. Molander P, Sipponen T, Kemppainen H, Jussila A, Blomster T, Koskela R, et al. Achievement of deep remission during scheduled maintenance therapy with TNFα-blocking agents in IBD. J Crohns Colitis. 2013;7(9):730–5.

    Article  PubMed  Google Scholar 

  4. Froslie KF, Jahnsen J, Moum BA, Vatn MH, Group I. Mucosal healing in inflammatory bowel disease: results from a Norwegian population-based cohort. Gastroenterology. 2007;133(2):412–22.

    Article  PubMed  Google Scholar 

  5. Tajra JB, Calegaro JU, de Paula AP, Bachour D, Silveira D, Lozi M, et al. Correlation and concordance measures between clinical, endoscopic and histological scores activity in Crohn's disease under treatment. Scand J Gastroenterol. 2019;54(4):441–5.

    Article  PubMed  Google Scholar 

  6. Gong W, Guo K, Zheng T, Fang M, Xie H, Li W, et al. Correlation between endoscopic and histological validated scoring indices in Crohn's disease. Dig Liver Dis. 2019;51(6):812–7.

    Article  PubMed  Google Scholar 

  7. Castiglione F, Mainenti P, Testa A, Imperatore N, De Palma GD, Maurea S, et al. Cross-sectional evaluation of transmural healing in patients with Crohn's disease on maintenance treatment with anti-TNF alpha agents. Dig Liver Dis. 2017;49(5):484–9.

    Article  CAS  PubMed  Google Scholar 

  8. Goetz M. Endoscopic surveillance in inflammatory bowel disease. Visc Med. 2018;34(1):66–71.

    Article  PubMed  PubMed Central  Google Scholar 

  9. Asli IN, Ehsani MJ, Javadi H, Semnani S, Tabib SM, Assadi M. Comparison of three with six regions of interest analyses in patients with idiopathic constipation undertaking colon transit scintigraphy using 67Ga-citrate. Eur Rev Med Pharmacol Sci. 2013;17(1):69–74.

    CAS  PubMed  Google Scholar 

  10. Becker W, Meller J. The role of nuclear medicine in infection and inflammation. Lancet Infect Dis. 2001;1(5):326–33.

    Article  CAS  PubMed  Google Scholar 

  11. Bellen JC, Chatterton BE, Penglis S, Tsopelas C. Gallium-67 complexes as radioactive markers to assess gástrico and colonic transit. J Nucl Med. 1995;36:513–7.

    CAS  PubMed  Google Scholar 

  12. Joseph U, Jhingran SG, Johnson PC. Gallium-67 imaging and Crohn's disease. J Nucl Med. 1979;20(8):903–4.

    CAS  PubMed  Google Scholar 

  13. Othman MF, Mitry NR, Lewington VJ, Blower PJ, Terry SY. Re-assessing gallium-67 as a therapeutic radionuclide. Nucl Med Biol. 2017;46:12–8.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  14. Baumgart DCSW. Crohn`s disease. Lancet. 2012;380:1590–605.

    Article  PubMed  Google Scholar 

  15. Gomollón F, Dignass A, Annese V, Tilg H, Van Assche G, Lindsay JO, et al. 3rd European evidence-based consensus on the diagnosis and management of Crohn's disease 2016: part 1: diagnosis and medical management. J Crohns Colitis. 2017;11(1):3–25.

    Article  PubMed  Google Scholar 

  16. Siegel JA, Wu RK, Knight LC, Zelac RE, Stern HS, Malmud LS. Radiation dose estimates for oral agents used in upper gastrointestinal disease. J Nucl Med. 1983;24:835–7.

    CAS  PubMed  Google Scholar 

  17. Lai EJ, Calderwood AH, Doros G, Fix OK, Jacobson BC. The Boston bowel preparation scale: a valid and reliable instrument for colonoscopy-oriented research. Gastrointest Endosc. 2009;69(3 Pt 2):620–5.

    Article  PubMed  PubMed Central  Google Scholar 

  18. Khanna R, Zou G, D'Haens G, Rutgeerts P, McDonald JW, Daperno M, et al. Reliability among central readers in the evaluation of endoscopic findings from patients with Crohn's disease. Gut. 2016;65(7):1119–25.

    Article  PubMed  Google Scholar 

  19. Magro F, Langner C, Driessen A, Ensari A, Geboes K, Mantzaris GJ, et al. European consensus on the histopathology of inflammatory bowel disease. J Crohns Colitis. 2013;7(10):827–51.

    Article  CAS  PubMed  Google Scholar 

  20. Naini BV, Cortina G. A histopathologic scoring system as a tool for standardized reporting of chronic (ileo)colitis and independent risk assessment for inflammatory bowel disease. Hum Pathol. 2012;43(12):2187–96.

    Article  PubMed  Google Scholar 

  21. Joseph NE WC. Pathology of Inflammatory Bowel Disease. Crohn´s Disease and Ulcerative Colitis. I. Canada: Springer; 2017.

  22. Genders TS, Spronk S, Stijnen T, Steyerberg EW, Lesaffre E, Hunink MG. Methods for calculating sensitivity and specificity of clustered data: a tutorial. Radiology. 2012;265(3):910–6.

    Article  PubMed  Google Scholar 

  23. Rao JN, Scott AJ. A simple method for the analysis of clustered binary data. Biometrics. 1992;48(2):577–85.

    Article  CAS  PubMed  Google Scholar 

  24. Yang Z, Zhou M. Kappa statistic for clustered matched-pair data. Stat Med. 2014;33(15):2612–33.

    Article  PubMed  Google Scholar 

  25. Gilletta C, Lewin M, Bourrier A, Nion-Larmurier I, Rajca S, Beaugerie L, et al. Changes in the Lémann Index values during the first years of Crohn's disease. Clin Gastroenterol Hepatol. 2015;13(9):1633–40.

    Article  PubMed  Google Scholar 

  26. Sandborn WJ, Feagan BG, Hanauer SB, Lochs H, Löfberg R, Modigliani R, et al. A review of activity indices and efficacy endpoints for clinical trials of medical therapy in adults with Crohn's disease. Gastroenterology. 2002;122(2):512–30.

    Article  PubMed  Google Scholar 

  27. Zittan E, Kelly OB, Kirsch R, Milgrom R, Burns J, Nguyen GC, et al. Low fecal calprotectin correlates with histological remission and mucosal healing in ulcerative colitis and colonic Crohn's disease. Inflamm Bowel Dis. 2016;22(3):623–30.

    Article  PubMed  Google Scholar 

  28. Zakeri N, Pollok RC. Diagnostic imaging and radiation exposure in inflammatory bowel disease. World J Gastroenterol. 2016;22(7):2165–78.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  29. Xavier RJ, Podolsky DK. Unravelling the pathogenesis of inflammatory bowel disease. Nature. 2007;448(7152):427–34.

    Article  CAS  PubMed  Google Scholar 

  30. de Bruyn M, Arijs I, De Hertogh G, Ferrante M, Van Assche G, Rutgeerts P, et al. Serum neutrophil gelatinase B-associated lipocalin and matrix metalloproteinase-9 complex as a surrogate marker for mucosal healing in patients with Crohn's disease. J Crohns Colitis. 2015;9(12):1079–87.

    Article  PubMed  Google Scholar 

  31. de Souza HS, Fiocchi C. Immunopathogenesis of IBD: current state of the art. Nat Rev Gastroenterol Hepatol. 2016;13(1):13–27.

    Article  PubMed  Google Scholar 

Download references

Funding

This work was supported by the Base Hospital Institute through the Endoscopic Center and Pathology Department.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to João Batista Monteiro Tajra.

Ethics declarations

Conflict of interest

None of the authors have any financial interests or conflict of interest to declare.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Tajra, J.B.M., Calegaro, J.U., de Paula, A.P. et al. Accuracy of Oral 67Gallium Citrate Scintigraphy in assessment of inflammatory activity of Crohn’s disease. Ann Nucl Med 34, 263–271 (2020). https://doi.org/10.1007/s12149-020-01447-w

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12149-020-01447-w

Keywords

Navigation